Warfarin still number one anticoagulant
22nd August 2012
Uptake of the new anticoagulants has been slow in the US, with most atrial fibrillation patients staying on warfarin, registry data suggest.
Just 12.6% of anticoagulated patients were taking dabigatran and rivaroxaban in 2011, with the remainder taking warfarin, according to figures from the PINNACLE registry, which includes over 121,000 AF patients.
A little less than 50% of patients were taking any form of anticoagulation — consistent with previous